Revance Therapeutics News

Revance Therapeutics | 8-K: Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update

May 9 15:16

Revance Therapeutics | 8-K: Current report

May 3 15:07

Revance Therapeutics | DEFA14A: Others

Mar 21 15:13

Revance Therapeutics | DEF 14A: Definitive information statements

Mar 21 15:12

Revance Therapeutics | 8-K: Current report

Mar 5 16:09

Revance Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 29 12:28

Revance Therapeutics | 8-K: Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update

Feb 28 15:15

Revance Therapeutics | 8-K: Current report

Feb 13 15:33

Revance Therapeutics | 8-K: Current report

Feb 6 15:11

Revance Therapeutics | 8-K: Revance Provides Corporate Update, Preliminary Fourth Quarter and Full Year 2023 Financial Results, and Financial Outlook

Jan 7 23:00

Revance Therapeutics | 8-K: Current report

Dec 15, 2023 15:04

Revance Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Nov 14, 2023 15:22

Revance Therapeutics | 8-K: Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update

Nov 8, 2023 15:09

Revance Therapeutics | 8-K: Current report

Sep 19, 2023 08:01

Revance Therapeutics | 8-K: Current report

Aug 30, 2023 18:20

Revance Therapeutics | 8-K: Current report

Aug 14, 2023 07:02

Revance Therapeutics | 8-K: Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update

Aug 8, 2023 15:08

Revance Therapeutics | 8-K: Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update

May 9, 2023 15:07

Revance Therapeutics | 8-K: Current report

May 8, 2023 15:08

Revance Therapeutics | 8-K: Current report

Apr 19, 2023 15:06